Impact of high external load resistance and low external load resistance training with blood flow restriction on anterior cruciate ligament volume in healthy female and male adults: A randomized controlled trial
Osterloh J, Mau-Moeller A, Knaack F, Holl N, Lappe C, Polei S et al. · Research Square · 2026
Abstract
Background: Anterior cruciate ligament (ACL) volume is positively correlated with quadriceps femoris (QF) muscle volume. Given that a smaller ACL size is associated with higher risk for injuries, this study investigated the effect of hypertrophy-focused high external load resistance training (HLRT) and low external load resistance training combined with blood flow restriction (LLRT-BFR) on ACL and QF volume.
Methods: Sixty healthy adults (n = 33 females) were randomly assigned to two training groups (HLRT or LLRT-BFR, 16 weeks, 3 sessions/week) and a control group (CG). ACL and QF volume were assessed by 3-Tesla magnetic resonance imaging before and after the interventions. Analysis of covariance with baseline-adjustment was conducted using per-protocol (n = 47) and intention-to-treat (n = 60) analyses, with sex as additional factor, followed by Tukey post-hoc tests (p ≤ 0.050) and the calculation of effect sizes.
Results: Per-protocol analysis indicated a group effect (p = 0.044, η p 2 = 0.155) with a higher ACL volume in the LLRT-BFR compared to the HLRT group (p = 0.041, d = 1.007) and a non-significantly higher ACL volume, with a nearly large effect size, compared to the CG (p = 0.142, d = 0.758). This effect was predominantly observed in male participants (p ≤ 0.094, d ≥ 1.670). Moreover, a group effect was found for QF volume (p p 2 = 0.545) with higher values in both training groups compared to CG (p 2.000).
Results of the per-protocol and the intention-to-treat analyses were consistent.
Conclusions: ACL volume was increased after LLRT-BFR compared to HLRT and CG, predominantly in males, while OF volume was higher after both interventions. These
Findings: open new perspectives for ACL injury prevention. Trial Registration: The trial was prospectively registered in the German Clinical Trial Register (DRKS00031249) on 17/02/2023 and adhered to the published protocol (https://drks.de/search/de/trial/DRKS00031249).